“license” Archives

in
Entry Author Date Location
Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections 03/26/20 San Diego
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
To Catch Early Cancer, and Rivals, Thrive Banks on Hopkins Blood Test 05/30/19 Boston
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding 04/30/19 Texas
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
New CRISPR Fight: Old Friends Intellia, Caribou in License Dispute 02/06/19 San Francisco
Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More 11/02/18 National
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango 10/31/18 San Francisco
Austin’s Factom Eyes Series B After $6M SAFE Deal With LSE Investor 08/07/18 Texas
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More 04/06/18 National
Ex-Kite Execs Resurface with $300M and Control of Pfizer CAR-T Cells 04/03/18 San Francisco
Bio Roundup: Trump Health, Cholesterol Wars, 23andMe OK & More 03/09/18 National
Bristol-Myers Bets Nearly $2B on Nektar for an Immunotherapy Boost 02/14/18 New York
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Bio Roundup: ICER Eyes Cost, Azar at HHS, Gates’s ALZ Cash & More 11/17/17 National
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Celgene Narrows Its Relationship With Sutro, No Acquisition Coming 08/10/17 New York
Experimental Drug With San Antonio Roots Changes Home After Merger 08/08/17 Texas
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points 08/07/17 Texas
Chinese Pharma Licenses Two Drugs from UT Schools For $4.5M Upfront 06/23/17 Texas
Cytori Reboots Azaya Facility After Buyout, Looks for European Deal 05/04/17 Texas
Magenta Nabs More Cash, Licenses Drug To Boost Transplant Pipeline 05/02/17 Boston
Factom, Blockchain-Based Records Startup, Adds to Series A Funding 04/18/17 Texas
Biotech With Drug Developed by San Antonio Researcher Explores Sale 03/09/17 Texas
Cytori Buys San Antonio-based Azaya’s Drug Delivery Tech for Stock 01/19/17 Texas
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Factom Snags $4.2M Series A for Record-Encrypting Blockchain Tech 10/05/16 Texas
A New Coat Makes The Difference in Rapamycin’s Disease Prevention 04/26/16 Texas
Page 1 of 2 next page »